🇺🇸 FDA
Patent

US 11844773

Solid solution compositions and use in chronic inflammation

granted A61KA61K31/12A61K31/121

Quick answer

US patent 11844773 (Solid solution compositions and use in chronic inflammation) held by Infirst Healthcare Limited expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/12, A61K31/121, A61K31/192, A61K31/196